PLAUR and melanoma: We transfected melanoma and colon cancer cells with two CRISPR/Cas9 D10A plasmids, each one bearing a specific sgRNA, as shown in Figure 1A, designed by the manufacturer to generate a double strand break in uPAR exon 3 (Figure 1B), thus obtaining a complete PLAUR gene knockout.